Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases.
Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases. The company was founded in 2013 and is based in Wauwatosa, Wisconsin.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 6, 2018 | Grant | $294.99K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |